Overview
Temenos AG, based in Geneva, Switzerland, is a leading provider of banking software systems to retail, corporate, universal, private, Islamic, and microfinance & community banks. The company operates in the Information Technology sector, specifically in the Software & Services industry. Its primary products include digital front office, core banking, payments, fund management, and wealth management software solutions.
AI+ Ask Fintel’s AI assistant about Temenos AG.
Thinking about good questions…
Basic Stats
The share price of Temenos AG as of May 23, 2024 is $63.99 / share. The market cap (or net worth) of Temenos AG as of September 5, 2025 is $4,504.35 MM.
The Factor Analysis chart (below right) shows a view of Temenos AG from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 4,504.35 MM |
| EV | 5,086.70 MM |
| Shares Out. | 70.39 MM |
| Earnings Date | |
| EPS (TTM) | 4.28 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-05-15 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | 14.94 |
| Price/Book | 8.44 |
| Price/TBV | -5.88 |
| Book/Market | 0.12 |
| EBIT/EV | 0.07 |
| EBIT(3yr avg)/EV | 0.05 |
| ROA | 0.13 |
| ROE | 0.43 |
| ROIC | 0.21 |
| CROIC | 0.08 |
| OCROIC | 0.25 |
| Implied Volatility | |
| Put/Call OI Ratio |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Temenos AG is $87.09. The forecasts range from a low of $64.31 to a high of $113.54. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Temenos AG. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2023-11-27 | HSBC | Hold | Hold | Maintains |
| 2023-10-31 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
| 2023-10-26 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2023-10-25 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2023-10-25 | BRYAN GARNIER | Buy | Buy | Maintains |
| 2023-10-25 | BAADER HELVEA EQUITY RESEARCH | Sell | Sell | Maintains |
| 2023-08-28 | HSBC | Hold | Hold | Maintains |
| 2023-08-27 | HSBC | Hold | Hold | Maintains |
| 2023-07-25 | BAADER HELVEA EQUITY RESEARCH | Sell | Sell | Maintains |
| 2023-07-24 | BAADER HELVEA EQUITY RESEARCH | Sell | Sell | Maintains |
| 2023-07-24 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
| 2023-07-24 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2023-07-23 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
| 2023-07-23 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2023-07-21 | CREDIT SUISSE - EUROPE | Underperform | Underperform | Maintains |
| 2023-07-21 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2023-07-20 | CREDIT SUISSE - EUROPE | Underperform | Underperform | Maintains |
| 2023-07-20 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2023-07-06 | BRYAN GARNIER | Sell | Buy | Upgrade |
| 2023-07-05 | BRYAN GARNIER | Sell | Buy | Upgrade |
| 2023-05-22 | HSBC | Buy | Hold | Downgrade |
| 2023-05-21 | HSBC | Buy | Hold | Downgrade |
| 2023-04-28 | STIFEL EUROPE | Buy | Hold | Downgrade |
| 2023-04-28 | BAADER HELVEA EQUITY RESEARCH | Sell | Sell | Maintains |
| 2023-04-27 | STIFEL EUROPE | Buy | Hold | Downgrade |
| 2023-04-27 | BAADER HELVEA EQUITY RESEARCH | Sell | Sell | Maintains |
| 2023-04-26 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
| 2023-04-26 | CREDIT SUISSE - EUROPE | Neutral | Underperform | Downgrade |
| 2023-04-25 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
| 2023-04-25 | CREDIT SUISSE - EUROPE | Neutral | Underperform | Downgrade |
| 2023-04-18 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2023-04-17 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2023-04-11 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2023-04-05 | BAADER HELVEA EQUITY RESEARCH | Sell | Sell | Maintains |
| 2023-04-03 | CREDIT SUISSE - EUROPE | Neutral | Underperform | Downgrade |
| 2023-03-28 | BRYAN GARNIER | Neutral | Sell | Downgrade |
| 2023-03-27 | BRYAN GARNIER | Neutral | Sell | Downgrade |
| 2023-03-27 | HSBC | Buy | Hold | Downgrade |
| 2023-03-22 | BNP PARIBAS EXANE | Outperform | Neutral | Downgrade |
| 2023-03-08 | STIFEL EUROPE | Buy | Hold | Downgrade |
| 2023-01-16 | BRYAN GARNIER | Buy | Neutral | Downgrade |
| 2023-01-15 | BRYAN GARNIER | Buy | Neutral | Downgrade |
| 2022-10-21 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2022-10-20 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2022-10-06 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2022-10-05 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2022-08-22 | HSBC | Buy | Buy | Maintains |
| 2022-08-21 | HSBC | Buy | Buy | Maintains |
| 2022-07-22 | BRYAN GARNIER | Buy | Buy | Maintains |
| 2022-07-21 | BRYAN GARNIER | Buy | Buy | Maintains |
| 2022-07-13 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2022-07-12 | BNP PARIBAS EXANE | Outperform | Outperform | Maintains |
| 2022-03-30 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2022-03-29 | CREDIT SUISSE - EUROPE | Neutral | Neutral | Maintains |
| 2022-02-14 | BAADER HELVEA EQUITY RESEARCH | Sell | Sell | Maintains |
| 2022-02-13 | BAADER HELVEA EQUITY RESEARCH | Sell | Sell | Maintains |
| 2020-10-23 | BERENBERG | Hold | Hold | Maintains |
| 2024-08-05 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
| 2024-07-28 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2024-07-23 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2024-05-26 | HSBC | Hold | Hold | Maintains |
| 2024-02-21 | STIFEL EUROPE | Hold | Buy | Upgrade |
| 2023-11-26 | HSBC | Hold | Hold | Maintains |
| 2023-10-30 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
| 2023-10-25 | STIFEL EUROPE | Hold | Hold | Maintains |
| 2023-10-24 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2023-10-24 | BRYAN GARNIER | Buy | Buy | Maintains |
| 2023-10-24 | BAADER HELVEA EQUITY RESEARCH | Sell | Sell | Maintains |
| 2025-03-23 | HSBC | Hold | Hold | Maintains |
| 2025-02-20 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2025-02-18 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2025-02-17 | JEFFERIES | Buy | Buy | Maintains |
| 2024-11-24 | HSBC | Hold | Hold | Maintains |
| 2024-11-18 | BNP PARIBAS EXANE | Neutral | Neutral | Maintains |
| 2024-11-17 | RESEARCH PARTNERS AG | Buy | Buy | Maintains |
| 2024-11-12 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2025-04-22 | STIFEL EUROPE | Buy | Buy | Maintains |
| 2025-06-30 | JEFFERIES | Buy | Buy | Maintains |
| 2025-05-25 | HSBC | Hold | Hold | Maintains |
